Billionaire Profile
Otto Boehringer
Global Rank
#602

Image: Fritz Rehm (1871-1928) | Public domain | via Wikimedia Commons

Otto Boehringer

CEO, Pharmaceuticals
GERMANY
Real-Time Net Worth
$6.636B
Estimated based on Pharmaceuticals stock value as of April 21, 2026
0% (24h)
Age
95
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
GERMANY

Biography

Otto Boehringer, at 95 years old, is a prominent figure in the pharmaceutical industry. His wealth stems from his family's ownership of Boehringer Ingelheim, one of the world's largest privately-owned pharmaceutical companies. Boehringer Ingelheim's global presence, with operations in numerous countries and a workforce exceeding 50,000, is a testament to its impact. The company's success is rooted in its commitment to research and development, resulting in innovative medicines that have transformed the lives of countless patients. The company's annual revenue is in the billions.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life

Otto Boehringer's early life details are not widely available in the public domain. However, his lineage connects him to the Boehringer family, founders of Boehringer Ingelheim.

Rise to Success

Otto Boehringer's wealth is directly tied to Boehringer Ingelheim. Founded in 1885 by Albert Boehringer, the company has grown into a global pharmaceutical giant. The Boehringer, Liebrecht, and von Baumbach families, including Otto, share ownership of the company. Boehringer Ingelheim operates in 78 countries and employs around 54,000 people. The company's focus on human pharmaceuticals, animal health, and biopharmaceuticals has driven its consistent growth, as shown by the 2024 sales of $29 billion.

Key Business Strategies

Boehringer Ingelheim's business strategies include a strong emphasis on research and development. The company invests approximately 20-25% of its annual revenue into R&D. This long-term orientation prioritizes innovation over short-term gains. The company has also expanded through strategic acquisitions and partnerships, such as the 2020 acquisition of Northern Biologics Inc.

Philanthropy

The search results did not provide the exact amounts of Otto Boehringer's or the Boehringer Ingelheim's philanthropy.

Career Milestones

1885

Foundation of Boehringer Ingelheim

Albert Boehringer founded a small tartar factory in Ingelheim am Rhein, Germany, which laid the foundation for the global pharmaceutical company.

Philanthropy & Social Impact

Information not found.

Information not found.

Undisclosed

Information on specific philanthropic initiatives is unavailable.

Business Philosophy & Leadership

Notable Quotes

"Information on notable quotes is unavailable."

Leadership Principles

Information not found.

Information on leadership principles is unavailable.

Controversies & Challenges

2023

EU Drug Ingredient Cartel

Boehringer Ingelheim was fined by the European Commission for operating a cartel to dominate the market for a specific drug ingredient in Europe.

2012

Improper Marketing

Boehringer Ingelheim agreed to pay $95 million to resolve allegations relating to the improper promotion of various drugs.

2026

Whistleblower Lawsuit

Boehringer Ingelheim faces a lawsuit from a former employee alleging retaliation for raising safety concerns.